Serum Cystatin, Chemokine, and Gastrin-Releasing Peptide Precursors and Their Clinical Value in Patients with Chronic Renal Failure

Table 2

Comparison of the expression levels of CysC, Chemerin, ProGRP, and Scr in the observation group and the control group.

Group	Number of cases	CysC (mg/L)	Chemerin (μg/L)	ProGRP (pg/mL)	Scr (mu mol/L)
Control groups	50
Observation group	98
		20.500	12.220	14.001	17.080
		<0.001	<0.001	<0.001	<0.001